Mucoactive agents in the therapy of upper respiratory airways infections: fair to describe them just as mucoactive?
F Scaglione, O Petrini - Clinical Medicine Insights: Ear, Nose …, 2019 - journals.sagepub.com
Background: Upper and lower respiratory tract infections are common conditions for which
medical advice is sought, and their management relies on the use of prescription and over …
medical advice is sought, and their management relies on the use of prescription and over …
Over‐the‐counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
CC Chang, AC Cheng… - Cochrane Database of …, 2014 - cochranelibrary.com
Background Cough is often distressing for patients with pneumonia. Accordingly they often
use over‐the‐counter (OTC) cough medications (mucolytics or cough suppressants). These …
use over‐the‐counter (OTC) cough medications (mucolytics or cough suppressants). These …
[HTML][HTML] Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model
A Karateke, R Dokuyucu, H Dogan, T Ozgur… - Medical Principles and …, 2019 - karger.com
Objective: Polycystic ovary syndrome (PCOS) is a serious endocrine disorder. In the present
study, we investigated the therapeutic effects of erdosteine in letrozole-induced PCOS in …
study, we investigated the therapeutic effects of erdosteine in letrozole-induced PCOS in …
Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology
GL Marseglia, S Manti, E Chiappini, I Brambilla… - Allergologia et …, 2021 - air.unipr.it
The current systematic review presented and discussed the most recent studies on acute
cough in pediatric age. After that, the Italian Society of Pediatric Allergy and Immunology …
cough in pediatric age. After that, the Italian Society of Pediatric Allergy and Immunology …
Cough remedies for children and adolescents: current and future perspectives
Cough is a widespread symptom in children and adolescents. Despite advances in scientific
knowledge about the neurophysiological mechanisms underlying the cough reflex, the best …
knowledge about the neurophysiological mechanisms underlying the cough reflex, the best …
Erdosteine: antitussive and anti-inflammatory effects
RWD Negro - Lung, 2008 - Springer
Erdosteine is a multifactorial drug currently used in COPD for its rheologic activity on
bronchial secretions and its positive effects on bacterial adhesiveness. Erdosteine produces …
bronchial secretions and its positive effects on bacterial adhesiveness. Erdosteine produces …
Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease
M Moretti - Expert review of respiratory medicine, 2007 - Taylor & Francis
Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic
properties and bacterial adhesion to the cell membrane, endowed with bronchial anti …
properties and bacterial adhesion to the cell membrane, endowed with bronchial anti …
Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases
R Dal Negro, E Pozzi, SG Cella - Pulmonary Pharmacology & Therapeutics, 2018 - Elsevier
Mucoactive drugs are commonly used in the treatment of acute respiratory tract diseases,
such as lower and acute respiratory infection and chronic bronchitis (CB) or chronic …
such as lower and acute respiratory infection and chronic bronchitis (CB) or chronic …
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study
E Crisafulli, O Coletti, S Costi, E Zanasi, C Lorenzi… - Clinical …, 2007 - Elsevier
Background: Mucus plugging and hypersecretion have been associated with an increased
relative risk of death in patients with bronchiectasis who may or may not have chronic …
relative risk of death in patients with bronchiectasis who may or may not have chronic …